Pillararene based supramolecular nanoplatform for endoplasmic reticulum-targeting type I photodynamic and NO gas therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin, 2024, 74: 12–4910.3322/caac.21820 ↗
2. Overchuk M, Weersink RA, Wilson BC, et al. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine. ACS Nano, 2023, 17: 7979–800310.1021/acsnano.3c00891 ↗
3. Xie Z, Fan T, An J, et al. Emerging combination strategies with phototherapy in cancer nanomedicine. Chem Soc Rev, 2020, 49: 8065–808710.1039/D0CS00215A ↗
4. Zhao X, Liu J, Fan J, et al. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application. Chem Soc Rev, 2021, 50: 4185–421910.1039/D0CS00173B ↗
5. Yang Y, Huang Z, Li LL. Advanced nitric oxide donors: chemical structure of NO drugs, NO nanomedicines and biomedical applications. Nanoscale, 2021, 13: 444–45910.1039/D0NR07484E ↗
6. Liu S, Li G, Ma D. Controllable nitric oxide-delivering platforms for biomedical applications. Adv Ther, 2022, 5: 210022710.1002/adtp.202100227 ↗
7. Huang W, Zhang J, Luo L, et al. Nitric oxide and tumors: from smallmolecule donor to combination therapy. ACS BioMater Sci Eng, 2023, 9: 139–15210.1021/acsbiomaterials.2c01247 ↗
8. Li X, Li X, Park S, et al. Photodynamic and photothermal therapy via human serum albumin delivery. Coord Chem Rev, 2024, 520: 21614210.1016/j.ccr.2024.216142 ↗
9. Yuan X, Zhou JL, Yuan L, et al. Phototherapy: progress, challenges, and opportunities. Sci China Chem, 2024, 68: 826–886510.1007/s11426-024-2411-7 ↗
10. Grayton QE, Phan TT, Kussatz CC, et al. Hyaluronic acid-coated silica nanoparticles for targeted delivery of nitric oxide to cancer cells. ACS Appl Bio Mater, 2024, 7: 3796–380910.1021/acsabm.4c00171 ↗
11. Kim N, Lee S, Park H, et al. Development of an intracellular nitric oxide-donating cell-penetrating polypeptide as an immunogenic cell death inducer. ACS Appl Bio Mater, 2024, 7: 6791–679910.1021/acsabm.4c00941 ↗
12. Wang Y, Huang X, Tang Y, et al. A light-induced nitric oxide controllable release nano-platform based on diketopyrrolopyrrole derivatives for pH-responsive photodynamic/photothermal synergistic cancer therapy. Chem Sci, 2018, 9: 8103–810910.1039/C8SC03386B ↗
13. Xu C, Pu K. Second near-infrared photothermal materials for combinational nanotheranostics. Chem Soc Rev, 2021, 50: 1111–113710.1039/D0CS00664E ↗
14. Sun J, Cai X, Wang C, et al. Cascade reactions by nitric oxide and hydrogen radical for anti-hypoxia photodynamic therapy using an activatable photosensitizer. J Am Chem Soc, 2021, 143: 868–87810.1021/jacs.0c10517 ↗
15. Li X, Kwon N, Guo T, et al. Innovative strategies for hypoxic-tumor photodynamic therapy. Angew Chem Int Ed, 2018, 57: 11522–1153110.1002/anie.201805138 ↗
16. Fan W, Huang P, Chen X. Overcoming the Achilles’ heel of photodynamic therapy. Chem Soc Rev, 2016, 45: 6488–651910.1039/C6CS00616G ↗
17. Wan Y, Fu LH, Li C, et al. Conquering the hypoxia limitation for photodynamic therapy. Adv Mater, 2021, 33: 210397810.1002/adma.202103978 ↗
18. Teng KX, Niu LY, Yang QZ. Supramolecular photosensitizer enables oxygen-independent generation of hydroxyl radicals for photodynamic therapy. J Am Chem Soc, 2023, 145: 4081–408710.1021/jacs.2c11868 ↗
19. Teng KX, Niu LY, Yang QZ. A host–guest strategy for converting the photodynamic agents from a singlet oxygen generator to a superoxide radical generator. Chem Sci, 2022, 13: 5951–595610.1039/D2SC01469F ↗
20. Teng K, Zhang D, Liu B, et al. Photo-induced disproportionation-mediated photodynamic therapy: simultaneous oxidation of tetrahydrobiopterin and generation of superoxide radicals. Angew Chem Int Ed, 2024, 63: 20231878310.1002/anie.202318783 ↗
21. Wang Y, Yang T, He Q. Strategies for engineering advanced nanomedicines for gas therapy of cancer. Natl Sci Rev, 2020, 7: 1485–151210.1093/nsr/nwaa034 ↗
22. Gao P, Pan W, Li N, et al. Boosting cancer therapy with organelletargeted nanomaterials. ACS Appl Mater Interfaces, 2019, 11: 26529–2655810.1021/acsami.9b01370 ↗
23. Xia J, Quan H, Huang Y, et al. Side chain programming synchronously enhances the photothermal conversion efficiency and photodynamic activity of A–D–A photosensitizers. ACS Macro Lett, 2024, 13: 489–49410.1021/acsmacrolett.4c00031 ↗
24. Xiao H, Li P, Hu X, et al. Simultaneous fluorescence imaging of hydrogen peroxide in mitochondria and endoplasmic reticulum during apoptosis. Chem Sci, 2016, 7: 6153–615910.1039/C6SC01793B ↗
25. Kand D, Pizarro L, Angel I, et al. Organelle-targeted BODIPY photocages: visible-light-mediated subcellular photorelease. Angew Chem Int Ed, 2019, 58: 4659–466310.1002/anie.201900850 ↗
26. Wang W, Zhang Y, Wang Z, et al. A native drug-free macromolecular therapeutic to trigger mutual reinforcing of endoplasmic reticulum stress and mitochondrial dysfunction for cancer treatment. ACS Nano, 2023, 17: 11023–1103810.1021/acsnano.3c03450 ↗
27. Zeng S, Wang Y, Chen C, et al. An ER-targeted, viscosity-sensitive hemicyanine dye for the diagnosis of nonalcoholic fatty liver and photodynamic cancer therapy by activating pyroptosis pathway. Angew Chem Int Ed, 2024, 63: 20231648710.1002/anie.202316487 ↗
28. Mehmood AH, Ullah F, Dong B, et al. Reaction-based small-molecule fluorescent probes for endoplasmic reticulum- and mitochondria-targeted biosensing and bioimaging. Sci China Mater, 2024, 67: 3491–353010.1007/s40843-024-3097-4 ↗
29. Zhang H, Liu Z, Zhao Y. Pillararene-based self-assembled amphiphiles. Chem Soc Rev, 2018, 47: 5491–552810.1039/C8CS00037A ↗
30. Ogoshi T, Kakuta T, Yamagishi T-. Applications of pillar[n]arene-based supramolecular assemblies. Angew Chem Int Ed, 2018, 58: 2197–220610.1002/anie.201805884 ↗
31. Wang C, Li H, Dong J, et al. Pillararene-based supramolecular vesicles for stimuli-responsive drug delivery. Chem Eur J, 2022, 28: e20220205010.1002/chem.202202050 ↗
32. Tang R, Ye Y, Zhu S, et al. Pillar[6]arenes: from preparation, host-guest property to self-assembly and applications. Chin Chem Lett, 2023, 34: 10773410.1016/j.cclet.2022.08.014 ↗
33. Zhou J, Rao L, Yu G, et al. Supramolecular cancer nanotheranostics. Chem Soc Rev, 2021, 50: 2839–289110.1039/D0CS00011F ↗
34. Li X, Shen M, Yang J, et al. Pillararene-based stimuli-responsive supramolecular delivery systems for cancer therapy. Adv Mater, 2024, 36: 231331710.1002/adma.202313317 ↗
35. Zhu H, Li Q, Khalil-Cruz LE, et al. Pillararene-based supramolecular systems for theranostics and bioapplications. Sci China Chem, 2021, 64: 688–70010.1007/s11426-020-9932-9 ↗
36. Feng W, Jin M, Yang K, et al. Supramolecular delivery systems based on pillararenes. Chem Commun, 2018, 54: 13626–1364010.1039/C8CC08252A ↗
37. Song YH, Bian Q, Wang F, et al. Water-soluble stimuli-responsive supramolecular nanoagrochemicals based on macrocycle compounds. Coord Chem Rev, 2025, 524: 21629910.1016/j.ccr.2024.216299 ↗
38. Feng Y, Qi S, Yu X, et al. Supramolecular modulation of tumor microenvironment through pillar[5]arene-based host–guest recognition to synergize cancer immunotherapy. J Am Chem Soc, 2023, 145: 18789–1879910.1021/jacs.3c03031 ↗
39. Zhu H, Wang H, Shi B, et al. Supramolecular peptide constructed by molecular Lego allowing programmable self-assembly for photodynamic therapy. Nat Commun, 2019, 10: 241210.1038/s41467-019-10385-9 ↗
40. Wu MX, Yan HJ, Gao J, et al. Multifunctional supramolecular materials constructed from polypyrrole@UiO-66 nanohybrids and pillararene nanovalves for targeted chemophotothermal therapy. ACS Appl Mater Interfaces, 2018, 10: 34655–3466310.1021/acsami.8b13758 ↗
41. Lu B, Xia J, Huang Y, et al. The design strategy for pillararene based active targeted drug delivery systems. Chem Commun, 2023, 59: 12091–1209910.1039/D3CC04021F ↗
42. Yu G, Yu W, Shao L, et al. Fabrication of a targeted drug delivery system from a pillar[5]arene-based supramolecular diblock copolymeric amphiphile for effective cancer therapy. Adv Funct Mater, 2016, 26: 8999–900810.1002/adfm.201601770 ↗
43. Wei P, Czaplewska JA, Wang L, et al. Straightforward access to glycosylated, acid sensitive nanogels by host–guest interactions with sugar-modified pillar[5]arenes. ACS Macro Lett, 2020, 9: 540–54510.1021/acsmacrolett.0c00030 ↗
44. Li J, Lv X, Li J, et al. A supramolecular near-infrared nanophoto-sensitizer from host-guest complex of lactose-capped pillar[5]arene with aza-BODIPY derivative for tumor eradication. Org Chem Front, 2023, 10: 1927–193510.1039/D3QO00065F ↗
45. Li D, Chen X, Dai W, et al. Photo-triggered cascade therapy: a NIR-II AIE luminogen collaborating with nitric oxide facilitates efficient collagen depletion for boosting pancreatic cancer phototheranostics. Adv Mater, 2024, 36: 230647610.1002/adma.202306476 ↗